NMR structures of components from human telomerase RNP

人端粒酶 RNP 成分的 NMR 结构

• 批准号: 6888087
• 负责人: THOMAS C LEEPER
• 金额: $ 4.99万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-04-26 至 2007-04-25
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6888087
• 关键词: RNA; binding sites; enzyme activity; enzyme structure; nuclear magnetic resonance spectroscopy; nucleic acid structure; postdoctoral investigator; protein biosynthesis; protein localization; protein structure; ribonucleoproteins; structural biology; telomerase; telomere

DESCRIPTION (provided by applicant): The ribonucleoprotein enzyme telomerase plays a major role in the cellular homeostasis and its regulation is believed to be one a key step in malignant transformation. This project seeks to study the structures of two regions from human telomerase RNA (hTR) with the long-term goal of presenting a framework from which drugs that fight cancer may be discovered. Protein accessory factors that interact with, and stabilize, one of these two domains will also be studied. The primary technique proposed is Nuclear Magnetic Resonance spectroscopy (NMR), which can be used to determine at atomic resolution the contacts formed within a biomolecule, such as a domain of hTR, and between molecules such as between hTR and the accessory protein NHP2. The specific domains to be studied are the 60-nucleotide CR4/CR5 domain of hTR that is crucial for activation of the telomerase holoenzyme, and the box H/ACA snoRNA-like domain. This second domain interacts with the four protein factors (Nhp2, Nop10, Gar1, and Diskerin) that stabilize hTR in vivo. Obtaining the structures of these domains would provide crucial insight into telomerase function and ultimately allow for the design of drugs that can interact with the RNA and thus attenuate tumor growth.

描述（由申请人提供）： 核糖核蛋白酶端粒酶在细胞内稳态中起着重要作用，其调节被认为是恶性转化的关键步骤之一。该项目旨在研究人类端粒酶RNA（hTR）的两个区域的结构，其长期目标是提出一个框架，从中可以发现抗癌药物。蛋白质辅助因子的相互作用，并稳定，这两个领域之一也将进行研究。所提出的主要技术是核磁共振光谱（NMR），其可用于以原子分辨率确定在生物分子内形成的接触，例如hTR的结构域，以及分子之间，例如hTR和辅助蛋白NHP 2之间。待研究的特定结构域是hTR的60个核苷酸的CR 4/CR 5结构域，其对于端粒酶全酶的活化至关重要，以及盒H/ACA snoRNA样结构域。第二个结构域与体内稳定hTR的四种蛋白质因子（Nhp 2，Nop 10，Gar 1和Diskerin）相互作用。获得这些结构域的结构将提供对端粒酶功能的重要见解，并最终允许设计可以与RNA相互作用的药物，从而减弱肿瘤生长。